LabCompass

Eric A. Singer

Medicine · The Ohio State University

Established · publishing since 1974Rising activity

Publications

733

Citations

8,414

Est. group size

~36

Recurring co-author estimate

Active years

53

Publishing since 1974

Research summary
AI-generated

Eric A. Singer's research focuses on urologic cancers, particularly kidney (renal cell), bladder (urothelial), and prostate cancer, spanning surgical treatment, systemic therapies (like immunotherapy and targeted drugs), and biomarkers for predicting patient outcomes. His work combines clinical trials, outcomes research, and molecular/genomic analyses (such as circulating tumor DNA and gene expression) aimed at improving diagnosis, treatment selection, and disparities in care.

Kidney and bladder cancer treatmentCancer immunotherapy and targeted therapyBiomarkers and circulating tumor DNASurgical oncology outcomesCancer health disparities

Publication output has grown substantially over the past decade, rising from about 18 papers per year in 2017 to a peak of nearly 200 in 2024, indicating a strongly increasing trend in research activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 87.8/year recently
2017: 18 publications172018: 24 publications182019: 26 publications192020: 54 publications202021: 50 publications212022: 50 publications222023: 71 publications232024: 194 publications194242025: 95 publications252026: 29 publications26
Recent publications
Publishes in
  • Journal of Clinical Oncology×64
  • The Journal of Urology×55
  • Urologic Oncology Seminars and Original Investigations×27
  • Elsevier eBooks×20
  • Urology×14
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile